---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-037065"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2023-10-12T23:59:59+00:00"
generated_at: "2026-06-10T00:48:52.897856+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# enVVeno raises $28M in PIPE financing with milestone-based warrants

## Summary
- Gross proceeds of $28M from sale of 3,844,704 shares, pre-funded warrants for 977,900 shares, and two tranches of warrants.
- Tranche A warrants (4,822,604 shares) at $6.945, expire 30 days post SAVVE top-line data or Oct 2024.
- Tranche B warrants (4,822,604 shares) at $8.334, expire 30 days post FDA PMA for VenoValve or Oct 2026.
- Net proceeds ~$25.9M; funds for VenoValve and enVVe development and working capital.
- Ladenburg Thalmann placement agent; 7% cash fee and warrants for 241,130 shares at $6.945.

## SEC filing metadata
- accession: 0001493152-23-037065
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2023-10-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000149315223037065/0001493152-23-037065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000149315223037065/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-037065
- JSON: https://secwatch.observer/filing/0001493152-23-037065.json
- Plain text: https://secwatch.observer/filing/0001493152-23-037065.txt

## Key facts
- Material Agreements
  enVVeno Medical Corp entered into Registration Rights Agreement with certain institutional investors (effective 2023-10-06).
  - Action: entry
  - Counterparty: certain institutional investors
  - Effective: 2023-10-06
  source text: In connection with the offering, the Company and the Investors entered into a Registration Rights Agreement dated October 6, 2023 (the “Registration Rights Agreement”), providing for the registration for resale of the Shares and Warrant Shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000149315223037065/0001493152-23-037065-index.htm
- Material Agreements
  enVVeno Medical Corp entered into Securities Purchase Agreement with certain institutional investors valued at approximately $28 million (effective 2023-10-06).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $28 million
  - Effective: 2023-10-06
  source text: On October 6, 2023, enVVeno Medical Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Investors”) for the purpose of raising approximately $28 million in gross proceeds for the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000149315223037065/0001493152-23-037065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.